摘要:
Disclosed is a novel human interferon-y polypeptide, a recombinant plasmid wherein a DNAfragment coding forthe polypeptide is incorporated, and a process for producing the human interferon-y polypeptide using a microorganism containing the plasmid.
摘要:
Disclosed are recombinant vector plasmids containing a DNA fragment coding for human interferon-β inserted downstream from a tryptophane promoter. The plasmids are useful for transformation of microorganisms such as Escherichia coli which transformants produce human interferon-β.
摘要:
Recombinant plasmids are constructed by inserting a DNA fragment coding for a fused protein of an adult T cell leukemia virus antigen peptide and an enzyme into a vector DNA. Microorganisms are transformed with the recombinant . plasmid and thereafter cultured to express the fused protein. The fused protein is useful for the detection and diagnosis of adult T cell leukamia.
摘要:
Recombinant plasmids are constructed by inserting a DNA fragment coding for a fused protein of an adult T cell leukemia virus antigen peptide and an enzyme into a vector DNA. Microorganisms are transformed with the recombinant . plasmid and thereafter cultured to express the fused protein. The fused protein is useful for the detection and diagnosis of adult T cell leukamia.
摘要:
Disclosed are recombinant vector plasmids containing a DNA fragment coding for human interferon-β inserted downstream from a tryptophane promoter. The plasmids are useful for transformation of microorganisms such as Escherichia coli which transformants produce human interferon-β.
摘要:
A method of assaying anti-ubiquitin antibody is provided which comprises allowing anti-ubiquitin antibody in a sample to bind to polyubiquitin supported on a solid phase, then allowing a labeled anti-human immunoglobulin specific antibody to bind to the bound anti-ubiquitin antibody, and assaying the label on said specific antibody.
摘要:
The present invention provides a method for detecting an anti-adult T cell leukemia virus antibody in a sample according to an immunological procedure using a polypeptide encoded by a fused gene comprising the gag gene of ATLV or a part thereof and the env gene of ATLV or a part thereof as an antigenic substance.